Search the GHTC website

Global health R&D delivers for Louisiana

US government investment in global health R&D has delivered

$86.8 million
to Louisiana research institutions
1,200+ new jobs
for Louisiana
Global health R&D at work in Louisiana

Researchers from Tulane University and Louisiana State University have helped discover a possible explanation for the rapid spread of Ebola. The team found that a compound known as the “delta peptide” is produced in large amounts in Ebola patients. The investigators theorize that it may be a specific type of viral protein that damages host cells by making their membranes become permeable; in the case of Ebola, this contributes to severe vomiting, internal bleeding, and extreme gastrointestinal distress in patients—in turn contributing to the virus’ spread. The discovery could lead to new treatments for this deadly and highly contagious disease.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: Army Medicine